CryoPort

$22.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.27 (-5.35%) As of 1:54 PM EDT today
-$1.27 (-5.35%) Today

Why Robinhood?

You can buy or sell CryoPort and other stocks, options, ETFs, and crypto commission-free!

About CYRX

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. Read More It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.

Employees
92
Headquarters
Irvine, California
Founded
1990
Market Cap
844.62M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
580.62K
High Today
$23.56
Low Today
$22.05
Open Price
$23.41
Volume
559.36K
52 Week High
$25.02
52 Week Low
$8.28

Collections

CYRX News

ReutersAug 17

Edited Transcript of CYRX earnings conference call or presentation 8-Aug-19 9:00pm GMT

5

CYRX Earnings

-$0.10
-$0.09
-$0.07
-$0.06
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 7, After Hours

More CYRX News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.